Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AMTX Stock Forecast 2026-2027
$1.91
Current Price
$134.40M
Market Cap
Buy 3
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to AMTX Price Targets
+1,366.0%
To High Target of $28.00
+554.5%
To Median Target of $12.50
+30.9%
To Low Target of $2.50
AMTX Price Momentum
-8.6%
1 Week Change
-16.6%
1 Month Change
-10.7%
1 Year Change
+37.4%
Year-to-Date Change
-49.7%
From 52W High of $3.80
+46.9%
From 52W Low of $1.30
📊 TOP ANALYST CALLS
Did AMTX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Aemetis is one of their latest high-conviction picks.
Latest AMTX Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, AMTX has a bullish consensus with a median price target of $12.50 (ranging from $2.50 to $28.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $1.91, the median forecast implies a 554.5% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AMTX Analyst Ratings
3
Buy
1
Hold
0
Sell
AMTX Price Target Range
Low
$2.50
Average
$12.50
High
$28.00
Current: $1.91
Latest AMTX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AMTX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 22, 2026 | Ascendiant Capital | Edward Woo | Buy | Maintains | $22.00 |
| Apr 8, 2026 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Nov 19, 2025 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Oct 6, 2025 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Jun 30, 2025 | UBS | Buy | Maintains | $N/A | |
| Jun 6, 2025 | Ascendiant Capital | Buy | Maintains | $N/A | |
| May 9, 2025 | UBS | Buy | Maintains | $N/A | |
| Mar 17, 2025 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Mar 14, 2025 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Dec 23, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Nov 15, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Sep 3, 2024 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Aug 19, 2024 | UBS | Buy | Maintains | $N/A | |
| Aug 2, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jul 31, 2024 | Truist Securities | Hold | Reiterates | $N/A | |
| May 13, 2024 | Truist Securities | Hold | Reiterates | $N/A | |
| May 10, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Mar 8, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Feb 21, 2024 | Stifel | Buy | Maintains | $N/A | |
| Jan 23, 2024 | Stifel | Buy | Maintains | $N/A |
Aemetis Inc. (AMTX) Competitors
The following stocks are similar to Aemetis based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Aemetis Inc. (AMTX) Financial Data
Aemetis Inc. has a market capitalization of $134.40M with a P/E ratio of -1.5x. The company generates $219.71M in trailing twelve-month revenue with a -33.8% profit margin.
Revenue growth is +27.4% quarter-over-quarter, while maintaining an operating margin of -11.6% and return on equity of +25.1%.
Valuation Metrics
Market Cap
$134.40M
Enterprise Value
$668.28M
P/E Ratio
-1.5x
PEG Ratio
0.1x
Price/Sales
0.6x
Growth & Margins
Revenue Growth (YoY)
+27.4%
Gross Margin
+5.0%
Operating Margin
-11.6%
Net Margin
-33.8%
EPS Growth
+27.4%
Financial Health
Cash/Price Ratio
+3.6%
Current Ratio
0.1x
Debt/Equity
-1.7x
ROE
+25.1%
ROA
-6.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Aemetis Inc. (AMTX) Business Model
About Aemetis Inc.
What They Do
Develops renewable fuels and biochemicals.
Business Model
Aemetis Inc. operates by producing renewable natural gas, ethanol, biodiesel, and various biochemicals from agricultural waste. The company generates revenue through the sale of these products, targeting markets that seek sustainable alternatives to petroleum-based products.
Additional Information
Founded in 2006 and based in Cupertino, California, Aemetis focuses on innovative technologies to lower carbon emissions. It has a diverse production portfolio, including significant facilities in California and India, and is actively involved in advancing sustainable aviation fuel and reducing environmental impacts through its circular bioeconomy strategy.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
223
CEO
Mr. Eric A. McAfee
Country
United States
IPO Year
2014
Website
www.aemetis.comAemetis Inc. (AMTX) Latest News & Analysis
Latest News
Quick Summary
Aemetis reported improved Q1 2026 revenues and gross margins but remains unprofitable, with $5M cash against $396M liabilities, raising concerns about its financial viability.
Why It Matters
Aemetis shows revenue growth but struggles with profitability and high debt. Ongoing financial instability raises concerns about its viability and future investment returns.
Source: Seeking Alpha
Market Sentiment:
Neutral
CPCFA Adopts Initial Resolution Supporting up to $1.1 Billion of Tax-Exempt Financing for Aemetis Projects
26 days ago
Quick Summary
Aemetis, Inc. (NASDAQ: AMTX) announced that California's CPCFA has adopted an Initial Resolution for potential future bond issuance of up to $1 million.
Why It Matters
Aemetis, Inc. gaining potential funding from California's CPCFA signals government support for renewable energy initiatives, potentially enhancing growth prospects and investor confidence.
Source: MCAP MediaWire
Market Sentiment:
Positive
Quick Summary
Aemetis, Inc. (NASDAQ: AMTX) reported a positive 1Q26, indicating progress in low-carbon fuel monetization and improved RNG economics, according to Stonegate Capital Partners.
Why It Matters
Aemetis' shift towards recurring low-carbon fuel revenue and improved RNG economics signals potential for stable growth, appealing to investors focused on sustainability and profitability.
Source: Newsfile Corp
Market Sentiment:
Neutral
Quick Summary
Aemetis, Inc. reported a 27% revenue growth, achieved positive gross profit, and increased dairy RNG production as of May 7, 2026.
Why It Matters
Aemetis, Inc.'s 27% revenue growth and positive gross profit signal strong business performance, while increased Dairy RNG production may enhance future profitability and market position.
Source: MCAP MediaWire
Market Sentiment:
Neutral
Quick Summary
Aemetis, Inc. (AMTX) has released its Q1 2026 earnings call transcript, providing insights into its financial performance and strategic developments for the quarter.
Why It Matters
The Q1 2026 earnings call for Aemetis, Inc. provides insights into the company’s financial performance, growth prospects, and operational challenges, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Aemetis (AMTX) reported a quarterly loss of $0.33 per share, worse than the expected loss of $0.27, but an improvement from a loss of $0.47 per share last year.
Why It Matters
Aemetis' larger-than-expected quarterly loss signals operational challenges, potentially impacting stock performance and investor confidence amid year-over-year improvement.
Source: Zacks Investment Research
Market Sentiment:
Negative
Frequently Asked Questions About AMTX Stock
What is Aemetis Inc.'s (AMTX) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Aemetis Inc. (AMTX) has a median price target of $12.50. The highest price target is $28.00 and the lowest is $2.50.
Is AMTX stock a good investment in 2026?
According to current analyst ratings, AMTX has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.91. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AMTX stock?
Wall Street analysts predict AMTX stock could reach $12.50 in the next 12 months. This represents a 554.5% increase from the current price of $1.91. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Aemetis Inc.'s business model?
Aemetis Inc. operates by producing renewable natural gas, ethanol, biodiesel, and various biochemicals from agricultural waste. The company generates revenue through the sale of these products, targeting markets that seek sustainable alternatives to petroleum-based products.
What is the highest forecasted price for AMTX Aemetis Inc.?
The highest price target for AMTX is $28.00 from at , which represents a 1,366.0% increase from the current price of $1.91.
What is the lowest forecasted price for AMTX Aemetis Inc.?
The lowest price target for AMTX is $2.50 from at , which represents a 30.9% increase from the current price of $1.91.
What is the overall AMTX consensus from analysts for Aemetis Inc.?
The overall analyst consensus for AMTX is bullish. Out of 2 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $12.50.
How accurate are AMTX stock price projections?
Stock price projections, including those for Aemetis Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 16, 2026 10:21 AM UTC